Miguel Encinas-Gimenez

Mr. Miguel Encinas-Gimenez

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2022 in Chemical Science
Verified
Journal Article
Open access
PDF file
JAJavier Bonet Aletá
Javier Bonet Aletá
MEMiguel Encinas-Gimenez
Miguel Encinas-Gimenez
Esteban UrriolabeitiaEsteban Urriolabeitia
Esteban Urriolabeitia
PMPilar Martin-Duque
Pilar Martin-Duque
Jose L. HuesoJose L. Hueso
Jose L. Hueso
JSJesus Santamaria
Jesus Santamaria
The present work sheds light on a generally overlooked issue in the emerging field of bio-orthogonal catalysis within tumour microenvironments (TMEs): the interplay between homogeneous and heterogeneous catalytic processes. In most cases, previous works dealing with nanoparticle-based catalysis in the TME focus on the effects obtained (e.g. tumour cell death) and attribute the results to heterogeneous processes alone. The specific mechanisms are rarely substantiated and, furthermore, the possibility of a significant contribution of homogeneous processes by leached species – and the complexes that they may form with biomolecules – is neither contemplated nor pursued. Herein, we have designed a bimetallic catalyst nanoparticle containing Cu and Fe species and we have been able to describe the whole picture in a more complex scenario where both homogeneous and heterogeneous processes are coupled and fostered under TME relevant chemical conditions. We investigate the preferential leaching of Cu ions in the presence of a TME overexpressed biomolecule such as glutathione (GSH). We demonstrate that these homogeneous processes initiated by the released by Cu–GSH interactions are in fact responsible for the greater part of the cell death effects found (GSH, a scavenger of reactive oxygen species, is depleted and highly active superoxide anions are generated in the same catalytic cycle). The remaining solid CuFe nanoparticle becomes an active catalyst to supply oxygen from oxygen reduced species, such as superoxide anions (by-product from GSH oxidation) and hydrogen peroxide, another species that is enriched in the TME. This activity is essential to sustain the homogeneous catalytic cycle in the oxygen-deprived tumour microenvironment. The combined heterogeneous–homogeneous mechanisms revealed themselves as highly efficient in selectively killing cancer cells, due to their higher GSH levels compared to healthy cell lines.

Verified
Journal Article
Open access
PDF file
MEMiguel Encinas-Gimenez
Miguel Encinas-Gimenez
PMPilar Martin-Duque
Pilar Martin-Duque
AMAna Martín-Pardillos
Ana Martín-Pardillos
Deoxyribonucleic acid (DNA) represents the main reservoir of genetic information in the cells, which is why it is protected in the nucleus. Entry into the nucleus is, in general, difficult, as the nuclear membrane is a selective barrier to molecules longer than 40 kDa. However, in some cases, the size of certain nanoparticles (NPs) allows their internalization into the nucleus, thus causing a direct effect on the DNA structure. NPs can also induce indirect effects on DNA through reactive oxygen species (ROS) generation. In this context, nanomaterials are emerging as a disruptive tool for the development of novel therapies in a broad range of biomedical fields; although their effect on cell viability is commonly studied, further interactions with DNA or indirect alterations triggered by the internalization of these materials are not always clarified, since the small size of these materials makes them perfectly suitable for interaction with subcellular structures, such as the nucleus. In this context, and using as a reference the predicted interactions presented in a computational model, we describe and discuss the observed direct and indirect effects of the implicated nanomaterials on DNA.

17 February 2023 in Materials Today Chemistry
Verified
Journal Article
Open access
JAJavier Bonet Aletá
Javier Bonet Aletá
Jose L. HuesoJose L. Hueso
Jose L. Hueso
LSL. Sanchez-Uriel
L. Sanchez-Uriel
MEMiguel Encinas-Gimenez
Miguel Encinas-Gimenez
Silvia IrustaSilvia Irusta
Silvia Irusta
JSJ. Santamaria
J. Santamaria

13 August 2025 in Nanoscale
Verified
Journal Article
Closed access
PDF file
MEMiguel Encinas-Gimenez
Miguel Encinas-Gimenez
AMAna Martín-Pardillos
Ana Martín-Pardillos
JAJavier Bonet Aletá
Javier Bonet Aletá
Estela Pérez-RodríguezEstela Pérez-Rodríguez
Estela Pérez-Rodríguez
ARAna Rodríguez-Largo
Ana Rodríguez-Largo
PMPilar Martin-Duque
Pilar Martin-Duque
We present an in-depth study of the working mechanisms of CuFe@DMSA NPs with high capability of glutathione (GSH) depletion with simultaneous production of reactive oxygen species (ROS), showing a significant reduction of tumour growth in vivo.

5 December 2023 in ChemRxiv
Verified
Preprint
Open access
PDF file
JAJavier Bonet Aletá
Javier Bonet Aletá
MEMiguel Encinas-Gimenez
Miguel Encinas-Gimenez
MOMiku Oi
Miku Oi
APAidan T. Pezacki
Aidan T. Pezacki
Victor SebastianVictor Sebastian
Victor Sebastian
JSJesus Santamaria
Jesus Santamaria
Copper plays critical roles as a metal active site cofactor and metalloallosteric signal for enzymes involved in cell proliferation and metabolism, making it an attractive target for cancer therapy. In this study, we investigated the efficacy of polydopamine nanoparticles (PDA NPs), classically applied for metal removal from water, as a therapeutic strategy for depleting intracellular labile copper pools in triple negative breast cancer models through the metal-chelating groups present on PDA surface. By using the activity-based sensing probe FCP-1, we could track the PDA-induced labile copper depletion while leaving total copper levels unchanged, and link it to the selective MDA-MB-231 cell death. Further mechanistic investigations revealed that PDA NPs increased reactive oxygen species (ROS) levels, potentially through the inactivation of superoxide dismutase 1 (SOD1), a copper-dependent antioxidant enzyme. Additionally, PDA NPs were found to interact with the mitochondrial membrane, resulting in an increase in mitochondrial membrane potential, which may contribute to enhanced ROS production. We employed an in vivo tumor model to validate the therapeutic efficacy of PDA NPs. Remarkably, in the absence of any additional treatment, the presence of PDA NPs alone led to a significant reduction in tumor volume by a factor of 1.66 after 22 days of tumor growth. Our findings highlight the potential of PDA NPs as a promising therapeutic approach for selectively targeting cancer by modulating copper levels and inducing oxidative stress, leading to tumor growth inhibition as shown in these triple negative breast cancer models.

3 July 2023 in ChemRxiv
Verified
Preprint
Open access
PDF file
JAJavier Bonet Aletá
Javier Bonet Aletá
JAJuan Vicente Alegre-Requena
Juan Vicente Alegre-Requena
JMJavier Martin-Martin
Javier Martin-Martin
MEMiguel Encinas-Gimenez
Miguel Encinas-Gimenez
AMAna Martín-Pardillos
Ana Martín-Pardillos
JSJesus Santamaria
Jesus Santamaria
Catalytic cancer therapy is emerging as a powerful tool to target cancer cells by exploiting specific characteristics of the tumor microenvironment (TME). To this end, the catalytic activity of nanoparticles, enzymes and homogeneous catalysts is recruited to induce reactions that are damaging to cancer cells. Thus, the pro-drug activation approach uses chemical constructs that become toxic species inside the tumor, typically following removal of a protecting group. In contrast, TME-based catalytic strategies do not rely on the introduction of foreign species and instead use molecules that are already present in the TME. So far, only four processes have been explored in relation to cancer therapy, two oxidation reactions (glucose and glutathione), generation of reactive oxygen species (ROS) and production of oxygen to alleviate tumor hypoxia. This is surprising, since the rich chemical environment in tumor cells could in principle provide many other therapeutic opportunities. In particular, amino groups seem a suitable target, given the abundance of proteins and peptides in biological environments. Here we show that catalytic CuFe nanoparticles are able to foster transamination reactions between different amino acids and pyruvate, another key molecule that abounds in the TME. Transamination would then reduce the available aminoacid pool, which is likely to affect cell homeostasis and to effectively hinder tumor proliferation. After internalization of Cu-containing nanoparticles in U251-MG cells, we observed a significant decrease in glutamine and alanine levels up to 48 hours after treatment. In addition, we have found that not only simple amino acids, but also di- and tri-peptides undergo catalytic transamination when exposed to the Cu cations released by our nanoparticles, thus extending the range of the effects to other molecules such as GSSG. Mechanistic calculations for GSSG transamination revealed the formation of an imine between the oxo-group of pyruvate and the free -NH2 group of GSSG, followed by the coordination of the imine to Cu(II). Our results demonstrate that transamination reactions can be catalyzed in cellulo by Cu-releasing nanoparticles, adding a new reaction to the existing toolbox of catalytic therapies.